We suggested that the epigenetic changes of C/EBPα and AML1 participate in AML and MDS leukemogenesis, and ETO only transduces more signals at MDS, which leads to MDS cells to retain their ability to differentiate. The gene discussed is RUNX1T1; the disease is myelodysplastic syndrome.